ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0159

Prenatal and Early-Life Environmental Exposures in Juvenile-Onset Systemic Autoimmune Rheumatic Diseases

Takuma Ohnishi1, Megan Zhao1, Min Shi2, Adam Schiffenbauer3, Sharon Jackson3, Anna Jansen1, Nastaran Bayat4, Payam Farhadi1, Christine Parks2, Clarice Weinberg2, Frederick Miller5 and Lisa Rider6, 1National Institutes of Health/National Institute of Environmental Health Sciences, Bethesda, MD, 2National Institutes of Health/National Institute of Environmental Health Sciences, Research Triangle Park, NC, 3National Institute of Health/National Institute of Dental and Craniofacial Research, Bethesda, MD, 4National Institutes of Health/National Institute of Environmental Health Sciences, Gaithersburg, MD, 5National Institutes of Health/National Institute of Environmental Health Sciences, Chapel Hill, NC, 6National Institute of Environmental Health Sciences/National Institutes of Health, Environmental Autoimmunity Group, Bethesda, MD

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, Environmental factors, pregnancy, Smoking

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0145–0174) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic autoimmune rheumatic diseases (SARDs), including juvenile idiopathic arthritis (JIA), systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), and systemic sclerosis (SSc), are characterized by immune dysregulation. While genetic predisposition contributes to disease susceptibility, environmental exposures, including those during the prenatal period and early childhood, may potentially influence disease risk. Evidence regarding these early-life factors is limited and inconsistent. This study aimed to examine associations between early-life environmental exposures and juvenile-onset SARDs.

Methods: A case-control study included 124 probands with juvenile-onset SARDs diagnosed within 5 years (99 with juvenile IIM, 16 with JIA, 5 with SSc, and 4 with SLE), their same gender, close-in-age unaffected siblings (n=121), and demographically matched unrelated controls without autoimmune disease (n=90). The proband’s date of diagnosis served as the reference date for their siblings and matched controls. Participants resided in the United States or Canada. Parents of pediatric patients completed questionnaires on pregnancy complications, parental smoking during pregnancy, early-life exposures, and active smoking history. Paired analyses between probands and their siblings were performed using conditional logistic regression models adjusted for age. Probands and controls were compared by logistic regression analysis, adjusting for potential confounding variables including age, sex, race, ethnicity, and education level.

Results: The median age at reference date was 7.4 years for probands, 8.4 years for siblings, and 9.2 years for controls. Sex and race distributions did not differ significantly among groups: 62% of probands and siblings were female compared to 66% of controls; 85% of probands and siblings were White compared to 87% of controls. No significant differences in pregnancy complications or early-life exposures were observed between probands and their siblings. However, compared to controls, juvenile-onset SARDs were associated with multiple pregnancy complications (OR 1.57, CI:1.14–2.24), but not with any specific complication (Table). Prenatal parental smoking was also significantly associated with juvenile-onset SARDs (OR 4.81, CI:1.30–24.29). While maternal smoking rates were similar between groups, paternal smoking was more frequent in probands compared to controls (OR 7.43, CI:1.66–55.68). Early-life exposures, such as birth order, breastfeeding and soy formula use, did not differ significantly between probands and controls. Passive smoke exposure before reference age was also associated with juvenile-onset SARDs (OR 4.88, CI:1.38–23.51). Active smoking was uncommon, with one proband and two siblings reporting tobacco use.

Conclusion: The number of pregnancy complications was associated with juvenile-onset SARDs, without an association with a specific complication. Parental smoke exposure during prenatal and early-life periods was strongly associated with SARDs. These findings highlight the importance of pregnancy and early-life factors in these diseases.

Supporting image 1Table. Associations between prenatal and early-life environmental factors and participant role


Disclosures: T. Ohnishi: None; M. Zhao: None; M. Shi: None; A. Schiffenbauer: AstraZeneca, 11, Hope Pharmaceuticals, 5; S. Jackson: None; A. Jansen: None; N. Bayat: None; P. Farhadi: None; C. Parks: None; C. Weinberg: None; F. Miller: None; L. Rider: None.

To cite this abstract in AMA style:

Ohnishi T, Zhao M, Shi M, Schiffenbauer A, Jackson S, Jansen A, Bayat N, Farhadi P, Parks C, Weinberg C, Miller F, Rider L. Prenatal and Early-Life Environmental Exposures in Juvenile-Onset Systemic Autoimmune Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/prenatal-and-early-life-environmental-exposures-in-juvenile-onset-systemic-autoimmune-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prenatal-and-early-life-environmental-exposures-in-juvenile-onset-systemic-autoimmune-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology